To study the dynamics of GBM resistance and identify potential drug combination targets, we transduced PDGFRA (platelet-derived growth factor receptor alpha)-amplified, patient-derived glioma neurospheres (TS54325) with a barcoded lineage-tracing library (CellTag26), and treated the neurospheres with ispinesib. The gene discussed is PDGFRA; the disease is central nervous system cancer.